/
/
A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
This content is Free Access.
A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
2,388 Views
•
06:46 min
•
July 05, 2022
DOI:
Summary
Automatically generated
In line with the urgent need for screening for type 1 diabetes, celiac disease, and coronavirus disease 2019, we developed a high throughput 6-Plex electrochemiluminescence assay to simultaneously detect all four islet autoantibodies, tissue transglutaminase autoantibodies, and antibodies to the receptor binding domain of severe acute respiratory syndrome coronavirus 2.
Read Article
Cite this Article
Jia, X., He, L., Miao, D., Zhang, C., Rewers, M., Yu, L. A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19. J. Vis. Exp. (185), e63787, doi:10.3791/63787 (2022).
Copy